NCT02324335 2019-01-16BrilacidinInnovation Pharmaceuticals, Inc.Phase 2 Completed61 enrolled 12 charts
NCT00101582 2016-09-27Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck CancerSwedish Orphan BiovitrumPhase 3 Completed188 enrolled 19 charts
NCT00698204 2014-06-05Cox-2 Inhibition in Radiation-induced Oral MucositisUConn HealthPhase 2 Completed43 enrolled 10 charts